

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.66214215 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.66214215 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.46105636 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.46105636 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.38522177 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.03639521 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.03639521 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.03639521 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.73396542 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.69142700 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.68519391 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.47139454 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.43346290 |
| 14 | cysteine metabolic process (GO:0006534) | 5.40013223 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 5.32846376 |
| 16 | urea metabolic process (GO:0019627) | 5.08899774 |
| 17 | urea cycle (GO:0000050) | 5.08899774 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.04057656 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.03010655 |
| 20 | response to peptidoglycan (GO:0032494) | 4.96018771 |
| 21 | lysine catabolic process (GO:0006554) | 4.87752993 |
| 22 | lysine metabolic process (GO:0006553) | 4.87752993 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.85011916 |
| 24 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.84820924 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.82481314 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 4.79458517 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.79015457 |
| 28 | protein carboxylation (GO:0018214) | 4.79015457 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.77704912 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.77056812 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.66755609 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.64313608 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.63172299 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 4.56447597 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 4.50589403 |
| 36 | bile acid metabolic process (GO:0008206) | 4.49985735 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.46784017 |
| 38 | regulation of complement activation (GO:0030449) | 4.40057633 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.31269192 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.28348978 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.27119484 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.22184425 |
| 43 | glycine metabolic process (GO:0006544) | 4.21756213 |
| 44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.20928837 |
| 45 | indolalkylamine metabolic process (GO:0006586) | 4.19076301 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.19051691 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.19051691 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.19051691 |
| 49 | cellular biogenic amine catabolic process (GO:0042402) | 4.12559504 |
| 50 | amine catabolic process (GO:0009310) | 4.12559504 |
| 51 | serine family amino acid metabolic process (GO:0009069) | 4.11910016 |
| 52 | aldehyde catabolic process (GO:0046185) | 4.10802807 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.04066509 |
| 54 | urate metabolic process (GO:0046415) | 4.03374919 |
| 55 | T-helper 1 type immune response (GO:0042088) | 4.00674507 |
| 56 | reverse cholesterol transport (GO:0043691) | 3.99420079 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.98194627 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 3.98076552 |
| 59 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.97779987 |
| 60 | phospholipid efflux (GO:0033700) | 3.93622151 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 3.93115222 |
| 62 | low-density lipoprotein particle remodeling (GO:0034374) | 3.92381927 |
| 63 | negative regulation of sterol transport (GO:0032372) | 3.91521878 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 3.91521878 |
| 65 | ethanol oxidation (GO:0006069) | 3.90828887 |
| 66 | bile acid and bile salt transport (GO:0015721) | 3.89377647 |
| 67 | regulation of vitamin metabolic process (GO:0030656) | 3.88589036 |
| 68 | cellular glucuronidation (GO:0052695) | 3.88318563 |
| 69 | coenzyme catabolic process (GO:0009109) | 3.86956126 |
| 70 | acylglycerol homeostasis (GO:0055090) | 3.86208049 |
| 71 | triglyceride homeostasis (GO:0070328) | 3.86208049 |
| 72 | glutamate metabolic process (GO:0006536) | 3.85754315 |
| 73 | regulation of interferon-alpha production (GO:0032647) | 3.85399377 |
| 74 | serine family amino acid biosynthetic process (GO:0009070) | 3.85116855 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 3.83503458 |
| 76 | regulation of mononuclear cell migration (GO:0071675) | 3.82768394 |
| 77 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.82047866 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 3.81941899 |
| 79 | drug transmembrane transport (GO:0006855) | 3.78458259 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.76563883 |
| 81 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.76549147 |
| 82 | acetyl-CoA metabolic process (GO:0006084) | 3.75939522 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.74943639 |
| 84 | imidazole-containing compound metabolic process (GO:0052803) | 3.69163050 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67749939 |
| 86 | oligosaccharide catabolic process (GO:0009313) | 3.67412261 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 3.64552242 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64552242 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 3.64552242 |
| 90 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64552242 |
| 91 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64552242 |
| 92 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64552242 |
| 93 | short-chain fatty acid metabolic process (GO:0046459) | 3.63094458 |
| 94 | positive regulation of heat generation (GO:0031652) | 3.62851362 |
| 95 | detection of molecule of bacterial origin (GO:0032490) | 3.61540088 |
| 96 | NAD biosynthetic process (GO:0009435) | 3.60983625 |
| 97 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.60005205 |
| 98 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.60005205 |
| 99 | glycosphingolipid catabolic process (GO:0046479) | 3.59373296 |
| 100 | valine metabolic process (GO:0006573) | 3.58268602 |
| 101 | glucuronate metabolic process (GO:0019585) | 3.57811582 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.57811582 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.56418450 |
| 104 | cofactor catabolic process (GO:0051187) | 3.55331903 |
| 105 | drug catabolic process (GO:0042737) | 3.55294485 |
| 106 | NIK/NF-kappaB signaling (GO:0038061) | 3.55161654 |
| 107 | cholesterol efflux (GO:0033344) | 3.53206016 |
| 108 | regulation of podosome assembly (GO:0071801) | 3.52544577 |
| 109 | organic acid catabolic process (GO:0016054) | 3.52239064 |
| 110 | carboxylic acid catabolic process (GO:0046395) | 3.52239064 |
| 111 | regulation of chronic inflammatory response (GO:0002676) | 3.51938198 |
| 112 | fibrinolysis (GO:0042730) | 3.50985487 |
| 113 | myeloid dendritic cell differentiation (GO:0043011) | 3.49726546 |
| 114 | ketone body metabolic process (GO:1902224) | 3.49155836 |
| 115 | arginine metabolic process (GO:0006525) | 3.46202142 |
| 116 | complement activation, classical pathway (GO:0006958) | 3.45413728 |
| 117 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.44852358 |
| 118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.44187591 |
| 119 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.43933686 |
| 120 | fatty acid beta-oxidation (GO:0006635) | 3.43627580 |
| 121 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43333922 |
| 122 | carnitine metabolic process (GO:0009437) | 3.43323705 |
| 123 | cholesterol homeostasis (GO:0042632) | 3.43136079 |
| 124 | complement activation (GO:0006956) | 3.41053974 |
| 125 | sterol homeostasis (GO:0055092) | 3.40503157 |
| 126 | aspartate family amino acid catabolic process (GO:0009068) | 3.39673980 |
| 127 | fatty acid oxidation (GO:0019395) | 3.39509793 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 3.38486333 |
| 129 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.38331410 |
| 130 | cellular response to type I interferon (GO:0071357) | 3.38155732 |
| 131 | type I interferon signaling pathway (GO:0060337) | 3.38155732 |
| 132 | positive regulation of interferon-alpha production (GO:0032727) | 3.37984634 |
| 133 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.37983832 |
| 134 | plasma lipoprotein particle assembly (GO:0034377) | 3.37515494 |
| 135 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.36937264 |
| 136 | protein activation cascade (GO:0072376) | 3.36751041 |
| 137 | positive regulation of lipid catabolic process (GO:0050996) | 3.35982217 |
| 138 | response to type I interferon (GO:0034340) | 3.34178595 |
| 139 | regulation of chemokine biosynthetic process (GO:0045073) | 3.33574841 |
| 140 | regulation of fever generation (GO:0031620) | 3.31351006 |
| 141 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.30946541 |
| 142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28472071 |
| 143 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.23390857 |
| 144 | glycolipid catabolic process (GO:0019377) | 3.23173515 |
| 145 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.20219674 |
| 146 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.18888000 |
| 147 | regulation of interleukin-12 production (GO:0032655) | 3.18332341 |
| 148 | defense response to protozoan (GO:0042832) | 3.18287064 |
| 149 | response to protozoan (GO:0001562) | 3.18134962 |
| 150 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.15252414 |
| 151 | germinal center formation (GO:0002467) | 3.14929033 |
| 152 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.09755521 |
| 153 | monocyte chemotaxis (GO:0002548) | 3.06942517 |
| 154 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.05856298 |
| 155 | myeloid dendritic cell activation (GO:0001773) | 3.05780154 |
| 156 | cellular response to lipopolysaccharide (GO:0071222) | 3.04129043 |
| 157 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00581153 |
| 158 | negative regulation of lipid storage (GO:0010888) | 2.99439709 |
| 159 | positive regulation of type 2 immune response (GO:0002830) | 2.99172548 |
| 160 | cellular response to molecule of bacterial origin (GO:0071219) | 2.98665936 |
| 161 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.97156879 |
| 162 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96442031 |
| 163 | negative regulation of cell killing (GO:0031342) | 2.96442031 |
| 164 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.92344360 |
| 165 | granulocyte activation (GO:0036230) | 2.91431935 |
| 166 | ceramide catabolic process (GO:0046514) | 2.89106201 |
| 167 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88285079 |
| 168 | positive regulation of interleukin-6 production (GO:0032755) | 2.87815665 |
| 169 | positive regulation of interferon-beta production (GO:0032728) | 2.86783874 |
| 170 | response to muramyl dipeptide (GO:0032495) | 2.86152786 |
| 171 | detection of other organism (GO:0098543) | 2.85176634 |
| 172 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84945305 |
| 173 | cellular extravasation (GO:0045123) | 2.84890588 |
| 174 | dendritic cell differentiation (GO:0097028) | 2.84034051 |
| 175 | detection of external biotic stimulus (GO:0098581) | 2.81730723 |
| 176 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.80158744 |
| 177 | macrophage activation (GO:0042116) | 2.79347623 |
| 178 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.77953869 |
| 179 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.77112546 |
| 180 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75240001 |
| 181 | positive regulation of acute inflammatory response (GO:0002675) | 2.74259294 |
| 182 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.73901683 |
| 183 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.73306488 |
| 184 | cellular response to interferon-gamma (GO:0071346) | 2.72175107 |
| 185 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.71686110 |
| 186 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.71378849 |
| 187 | regulation of heat generation (GO:0031650) | 2.69540848 |
| 188 | regulation of cholesterol storage (GO:0010885) | 2.69533216 |
| 189 | myeloid cell activation involved in immune response (GO:0002275) | 2.69342140 |
| 190 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.67294308 |
| 191 | amino sugar catabolic process (GO:0046348) | 2.65574197 |
| 192 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.65460890 |
| 193 | regulation of growth of symbiont in host (GO:0044126) | 2.65460890 |
| 194 | negative regulation of growth of symbiont in host (GO:0044130) | 2.65460890 |
| 195 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.65460890 |
| 196 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.65352914 |
| 197 | regulation of T cell tolerance induction (GO:0002664) | 2.64899514 |
| 198 | B cell mediated immunity (GO:0019724) | 2.64174575 |
| 199 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.63977149 |
| 200 | detection of biotic stimulus (GO:0009595) | 2.63451059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.19629773 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.31182394 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.97123732 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.47500144 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81074743 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.42320764 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.21687337 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.48969040 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29465637 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.03443456 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.52432800 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.35646092 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32625799 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19558872 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.15561017 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3662792 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95232459 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85082159 |
| 19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80273993 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80037619 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77429876 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77135907 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74974128 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69253415 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67207044 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66392814 |
| 27 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.63714861 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62852799 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61021202 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54057842 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54004739 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46425115 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.41812692 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41345123 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41343788 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40713723 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40257832 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37411602 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.27474216 |
| 40 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26330290 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24362740 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24361675 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20603267 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16289768 |
| 45 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15283028 |
| 46 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13454055 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08450079 |
| 48 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08200231 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06426504 |
| 50 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00914194 |
| 51 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00430195 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99057944 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98957246 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97482392 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94193284 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92825230 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92586690 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92252127 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91167223 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90190582 |
| 61 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89565569 |
| 62 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89565569 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89322091 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88534263 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88331454 |
| 66 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88316561 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87833720 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86895048 |
| 69 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86674478 |
| 70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85629863 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85544396 |
| 72 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85433105 |
| 73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.85248588 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84986590 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84936952 |
| 76 | * MAF_26560356_Chip-Seq_TH1_Human | 0.84887740 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83145798 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81273290 |
| 79 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81227987 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80574130 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80035878 |
| 82 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79992791 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79019873 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78969982 |
| 85 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78309368 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77275891 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77241840 |
| 88 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77118580 |
| 89 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77118580 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76463530 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 0.76352083 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76297810 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76062861 |
| 94 | MYB_26560356_Chip-Seq_TH1_Human | 0.75850664 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.73403823 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 0.72583726 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71254444 |
| 98 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.70988196 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.70311716 |
| 100 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.69659748 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69427459 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.68975404 |
| 103 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.68425440 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67373992 |
| 105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67211082 |
| 106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65775853 |
| 107 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.65734479 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65534099 |
| 109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.65348364 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.65117217 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64367381 |
| 112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64082896 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63592009 |
| 114 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.63349040 |
| 115 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62647183 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62597535 |
| 117 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62561623 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.62321231 |
| 119 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.61541165 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.61064472 |
| 121 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.60367471 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.60178242 |
| 123 | MYB_26560356_Chip-Seq_TH2_Human | 0.60091339 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.59933272 |
| 125 | GATA3_26560356_Chip-Seq_TH2_Human | 0.59170821 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58859383 |
| 127 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.57240363 |
| 128 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.56988825 |
| 129 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.56546911 |
| 130 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.55676294 |
| 131 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.55619396 |
| 132 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.55364267 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55301107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.06424871 |
| 2 | MP0005360_urolithiasis | 6.79800141 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.33631720 |
| 4 | MP0005365_abnormal_bile_salt | 5.20980725 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.30689686 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.74512265 |
| 7 | MP0009840_abnormal_foam_cell | 3.41533069 |
| 8 | MP0003252_abnormal_bile_duct | 3.34345244 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.06440963 |
| 10 | MP0005332_abnormal_amino_acid | 2.82388224 |
| 11 | MP0005083_abnormal_biliary_tract | 2.64974800 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.63629663 |
| 13 | MP0003195_calcinosis | 2.47507668 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.43149399 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.19684286 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.18428528 |
| 17 | MP0000343_altered_response_to | 2.10163375 |
| 18 | MP0000609_abnormal_liver_physiology | 2.06310311 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.01815250 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.85148660 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.82895797 |
| 22 | MP0003186_abnormal_redox_activity | 1.81520573 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.79147816 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.72072995 |
| 25 | MP0006054_spinal_hemorrhage | 1.68375164 |
| 26 | MP0002998_abnormal_bone_remodeling | 1.57443889 |
| 27 | MP0003448_altered_tumor_morphology | 1.52996123 |
| 28 | MP0002405_respiratory_system_inflammati | 1.52562791 |
| 29 | MP0001764_abnormal_homeostasis | 1.51764128 |
| 30 | MP0005310_abnormal_salivary_gland | 1.51196222 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.50381244 |
| 32 | MP0003868_abnormal_feces_composition | 1.49843090 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.47434120 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.45897111 |
| 35 | MP0008004_abnormal_stomach_pH | 1.43013003 |
| 36 | MP0003436_decreased_susceptibility_to | 1.42893908 |
| 37 | MP0009764_decreased_sensitivity_to | 1.41064950 |
| 38 | MP0008469_abnormal_protein_level | 1.38139810 |
| 39 | MP0005451_abnormal_body_composition | 1.35973207 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.32675907 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.26643671 |
| 42 | MP0000598_abnormal_liver_morphology | 1.26347410 |
| 43 | MP0009763_increased_sensitivity_to | 1.25984696 |
| 44 | MP0000858_altered_metastatic_potential | 1.25854451 |
| 45 | MP0009278_abnormal_bone_marrow | 1.25733470 |
| 46 | MP0000604_amyloidosis | 1.25623067 |
| 47 | MP0005164_abnormal_response_to | 1.25193887 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.23941139 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.23941139 |
| 50 | MP0003646_muscle_fatigue | 1.19526497 |
| 51 | MP0009785_altered_susceptibility_to | 1.19389909 |
| 52 | MP0009697_abnormal_copulation | 1.18992893 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.18532397 |
| 54 | MP0003828_pulmonary_edema | 1.10148402 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.09439607 |
| 56 | MP0002419_abnormal_innate_immunity | 1.08346200 |
| 57 | MP0000685_abnormal_immune_system | 1.08003259 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.07024662 |
| 59 | MP0002254_reproductive_system_inflammat | 1.06523352 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.05573166 |
| 61 | MP0005025_abnormal_response_to | 1.03751384 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.02311050 |
| 63 | MP0003724_increased_susceptibility_to | 1.01422877 |
| 64 | MP0001853_heart_inflammation | 0.98767386 |
| 65 | MP0001542_abnormal_bone_strength | 0.98113755 |
| 66 | MP0005387_immune_system_phenotype | 0.97934204 |
| 67 | MP0001790_abnormal_immune_system | 0.97934204 |
| 68 | MP0004883_abnormal_blood_vessel | 0.97411515 |
| 69 | MP0003091_abnormal_cell_migration | 0.96791927 |
| 70 | MP0006082_CNS_inflammation | 0.95110167 |
| 71 | MP0005165_increased_susceptibility_to | 0.93939297 |
| 72 | MP0001800_abnormal_humoral_immune | 0.92432327 |
| 73 | MP0002398_abnormal_bone_marrow | 0.90391829 |
| 74 | MP0009642_abnormal_blood_homeostasis | 0.89555712 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 0.89414192 |
| 76 | MP0001845_abnormal_inflammatory_respons | 0.88789001 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.88340192 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 0.86401105 |
| 79 | MP0005390_skeleton_phenotype | 0.86368219 |
| 80 | MP0003950_abnormal_plasma_membrane | 0.86138135 |
| 81 | MP0005000_abnormal_immune_tolerance | 0.85188154 |
| 82 | MP0001663_abnormal_digestive_system | 0.83171935 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.81545191 |
| 84 | MP0003011_delayed_dark_adaptation | 0.81310072 |
| 85 | MP0004130_abnormal_muscle_cell | 0.80666264 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.80502236 |
| 87 | MP0002723_abnormal_immune_serum | 0.80029201 |
| 88 | MP0005408_hypopigmentation | 0.78522074 |
| 89 | MP0003075_altered_response_to | 0.77667608 |
| 90 | MP0002452_abnormal_antigen_presenting | 0.77499564 |
| 91 | MP0005647_abnormal_sex_gland | 0.76885940 |
| 92 | MP0001756_abnormal_urination | 0.76196550 |
| 93 | MP0008260_abnormal_autophagy | 0.76142885 |
| 94 | MP0002971_abnormal_brown_adipose | 0.75632007 |
| 95 | MP0004510_myositis | 0.75508758 |
| 96 | MP0002722_abnormal_immune_system | 0.75474333 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.74021303 |
| 98 | MP0003303_peritoneal_inflammation | 0.73741340 |
| 99 | MP0005535_abnormal_body_temperature | 0.73240107 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.72632451 |
| 101 | MP0005023_abnormal_wound_healing | 0.72459562 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.72361791 |
| 103 | MP0000920_abnormal_myelination | 0.72105667 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.72092346 |
| 105 | MP0003690_abnormal_glial_cell | 0.71624244 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70678610 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.70515453 |
| 108 | MP0005671_abnormal_response_to | 0.70073031 |
| 109 | MP0005166_decreased_susceptibility_to | 0.68423504 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.67352541 |
| 111 | MP0003795_abnormal_bone_structure | 0.67316616 |
| 112 | MP0000371_diluted_coat_color | 0.66725633 |
| 113 | MP0001873_stomach_inflammation | 0.65376184 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.64379159 |
| 115 | MP0005334_abnormal_fat_pad | 0.64331157 |
| 116 | MP0003279_aneurysm | 0.64235061 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.63806775 |
| 118 | MP0003763_abnormal_thymus_physiology | 0.63552686 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.62624543 |
| 120 | MP0005266_abnormal_metabolism | 0.60989785 |
| 121 | MP0002933_joint_inflammation | 0.59908824 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.59390880 |
| 123 | MP0000465_gastrointestinal_hemorrhage | 0.59296052 |
| 124 | MP0008874_decreased_physiological_sensi | 0.58855037 |
| 125 | MP0008873_increased_physiological_sensi | 0.58671484 |
| 126 | MP0000249_abnormal_blood_vessel | 0.58344671 |
| 127 | MP0001819_abnormal_immune_cell | 0.58003030 |
| 128 | MP0001661_extended_life_span | 0.57463967 |
| 129 | MP0002420_abnormal_adaptive_immunity | 0.57283578 |
| 130 | MP0004947_skin_inflammation | 0.57190021 |
| 131 | MP0005670_abnormal_white_adipose | 0.57082437 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.56377491 |
| 133 | MP0010307_abnormal_tumor_latency | 0.55489057 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.55131705 |
| 135 | MP0003638_abnormal_response/metabolism_ | 0.50669466 |
| 136 | MP0000716_abnormal_immune_system | 0.50500233 |
| 137 | MP0001533_abnormal_skeleton_physiology | 0.50288286 |
| 138 | MP0010368_abnormal_lymphatic_system | 0.48727916 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.48240819 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.48215300 |
| 141 | MP0002006_tumorigenesis | 0.47094099 |
| 142 | MP0003718_maternal_effect | 0.44392505 |
| 143 | MP0002429_abnormal_blood_cell | 0.43736528 |
| 144 | MP0001881_abnormal_mammary_gland | 0.43183382 |
| 145 | MP0003329_amyloid_beta_deposits | 0.42422113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.46216676 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.46216676 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.46216676 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.13589372 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.09640094 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.98161307 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.54572494 |
| 8 | Xanthomatosis (HP:0000991) | 5.51215705 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.39669339 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.10518346 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.91525068 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.71740537 |
| 13 | Complement deficiency (HP:0004431) | 4.70911049 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.49152675 |
| 15 | Joint hemorrhage (HP:0005261) | 4.47607548 |
| 16 | Optic neuritis (HP:0100653) | 4.44087810 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 4.44087810 |
| 18 | Orchitis (HP:0100796) | 4.43582013 |
| 19 | Dysostosis multiplex (HP:0000943) | 4.28108900 |
| 20 | Eczematoid dermatitis (HP:0000976) | 4.27227954 |
| 21 | Hyperammonemia (HP:0001987) | 4.18278108 |
| 22 | Recurrent abscess formation (HP:0002722) | 4.04819911 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 4.02986139 |
| 24 | Loss of speech (HP:0002371) | 4.00440245 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.00237006 |
| 26 | Disinhibition (HP:0000734) | 3.99329359 |
| 27 | Stomatitis (HP:0010280) | 3.95155338 |
| 28 | Ketosis (HP:0001946) | 3.91104589 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.90437576 |
| 30 | Myositis (HP:0100614) | 3.89066873 |
| 31 | Hyperglycinuria (HP:0003108) | 3.87846979 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84098328 |
| 33 | Hyperglycinemia (HP:0002154) | 3.82283905 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.81384588 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.78098861 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 3.75644643 |
| 37 | Epidermoid cyst (HP:0200040) | 3.74114023 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.70566750 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.67509478 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.67509478 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66253186 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 3.63575779 |
| 43 | Abnormality of complement system (HP:0005339) | 3.62138179 |
| 44 | Fat malabsorption (HP:0002630) | 3.54976258 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.53024687 |
| 46 | Hypoglycemic coma (HP:0001325) | 3.50961309 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.47831464 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.47831464 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.47831464 |
| 50 | Hypoalphalipoproteinemia (HP:0003233) | 3.47203593 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43775847 |
| 52 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.43108598 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 3.36340952 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36125691 |
| 55 | Mucopolysacchariduria (HP:0008155) | 3.30866405 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.30866405 |
| 57 | Myocardial infarction (HP:0001658) | 3.24861509 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 3.07490045 |
| 59 | Hypercholesterolemia (HP:0003124) | 3.05939321 |
| 60 | Ketoacidosis (HP:0001993) | 3.03508277 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00860991 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.99248603 |
| 63 | Hyperbilirubinemia (HP:0002904) | 2.97308132 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.96355899 |
| 65 | Mutism (HP:0002300) | 2.92354893 |
| 66 | Hematochezia (HP:0002573) | 2.89019745 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.86568945 |
| 68 | Conjugated hyperbilirubinemia (HP:0002908) | 2.86500153 |
| 69 | Delayed CNS myelination (HP:0002188) | 2.83186035 |
| 70 | Steatorrhea (HP:0002570) | 2.81002684 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.79783822 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.79737187 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.71862896 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71862896 |
| 75 | Vascular calcification (HP:0004934) | 2.71445125 |
| 76 | Recurrent skin infections (HP:0001581) | 2.70907949 |
| 77 | Increased IgM level (HP:0003496) | 2.70151686 |
| 78 | Vasculitis (HP:0002633) | 2.69416917 |
| 79 | Metabolic acidosis (HP:0001942) | 2.69111296 |
| 80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.66196734 |
| 81 | Hepatocellular carcinoma (HP:0001402) | 2.63666278 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.63646293 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.63398291 |
| 84 | Glomerulonephritis (HP:0000099) | 2.58423932 |
| 85 | Gout (HP:0001997) | 2.57880494 |
| 86 | Recurrent fungal infections (HP:0002841) | 2.57417811 |
| 87 | Nuclear cataract (HP:0100018) | 2.55950744 |
| 88 | Hemoptysis (HP:0002105) | 2.53302633 |
| 89 | Lethargy (HP:0001254) | 2.51123508 |
| 90 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.47468765 |
| 91 | Abnormality of T cell number (HP:0011839) | 2.45994851 |
| 92 | Gangrene (HP:0100758) | 2.44572304 |
| 93 | Skin nodule (HP:0200036) | 2.39793094 |
| 94 | Spastic diplegia (HP:0001264) | 2.38721616 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.37134679 |
| 96 | Gingival bleeding (HP:0000225) | 2.36941971 |
| 97 | Amyloidosis (HP:0011034) | 2.36293805 |
| 98 | T lymphocytopenia (HP:0005403) | 2.34979075 |
| 99 | Obstructive lung disease (HP:0006536) | 2.34913158 |
| 100 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34913158 |
| 101 | Progressive neurologic deterioration (HP:0002344) | 2.34525092 |
| 102 | Polyneuropathy (HP:0001271) | 2.34465810 |
| 103 | Metaphyseal irregularity (HP:0003025) | 2.32743684 |
| 104 | Spontaneous abortion (HP:0005268) | 2.32396770 |
| 105 | Cerebral edema (HP:0002181) | 2.31958607 |
| 106 | Purpura (HP:0000979) | 2.31392147 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 2.30759025 |
| 108 | Inappropriate behavior (HP:0000719) | 2.28331261 |
| 109 | Apathy (HP:0000741) | 2.27999650 |
| 110 | Diminished motivation (HP:0000745) | 2.27711502 |
| 111 | Upper motor neuron abnormality (HP:0002127) | 2.26803406 |
| 112 | Arterial thrombosis (HP:0004420) | 2.26540807 |
| 113 | Esophageal varix (HP:0002040) | 2.22955449 |
| 114 | Abnormality of iron homeostasis (HP:0011031) | 2.21937282 |
| 115 | Thrombophlebitis (HP:0004418) | 2.21543947 |
| 116 | Hepatosplenomegaly (HP:0001433) | 2.20253293 |
| 117 | Proximal tubulopathy (HP:0000114) | 2.19051095 |
| 118 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17653712 |
| 119 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17653712 |
| 120 | Irritability (HP:0000737) | 2.16154800 |
| 121 | Axonal loss (HP:0003447) | 2.15780823 |
| 122 | Recurrent viral infections (HP:0004429) | 2.15437697 |
| 123 | Acanthocytosis (HP:0001927) | 2.15136994 |
| 124 | Autoimmune hemolytic anemia (HP:0001890) | 2.14857715 |
| 125 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14487020 |
| 126 | Gingivitis (HP:0000230) | 2.14306941 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.13972349 |
| 128 | Neonatal onset (HP:0003623) | 2.13317175 |
| 129 | Urticaria (HP:0001025) | 2.11981012 |
| 130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.11849393 |
| 131 | Abnormality of urine glucose concentration (HP:0011016) | 2.11542071 |
| 132 | Glycosuria (HP:0003076) | 2.11542071 |
| 133 | Pancreatitis (HP:0001733) | 2.11319096 |
| 134 | Vomiting (HP:0002013) | 2.11143119 |
| 135 | Mitral stenosis (HP:0001718) | 2.09378108 |
| 136 | Encephalitis (HP:0002383) | 2.09127731 |
| 137 | Basal ganglia calcification (HP:0002135) | 2.07853238 |
| 138 | Petechiae (HP:0000967) | 2.07368947 |
| 139 | Prolonged neonatal jaundice (HP:0006579) | 2.06487202 |
| 140 | Interstitial pulmonary disease (HP:0006530) | 2.04969345 |
| 141 | Meningitis (HP:0001287) | 2.04429032 |
| 142 | Anorexia (HP:0002039) | 2.04427662 |
| 143 | Sensorimotor neuropathy (HP:0007141) | 2.02284292 |
| 144 | Menorrhagia (HP:0000132) | 2.01550474 |
| 145 | Leukocytosis (HP:0001974) | 2.01393391 |
| 146 | Recurrent bacterial skin infections (HP:0005406) | 2.01215857 |
| 147 | Abnormal gallbladder morphology (HP:0012437) | 2.00785828 |
| 148 | Cholelithiasis (HP:0001081) | 2.00736673 |
| 149 | Vacuolated lymphocytes (HP:0001922) | 1.99761795 |
| 150 | Nausea (HP:0002018) | 1.99293467 |
| 151 | Malnutrition (HP:0004395) | 1.98154939 |
| 152 | Agnosia (HP:0010524) | 1.98123254 |
| 153 | Increased serum ferritin (HP:0003281) | 1.97697349 |
| 154 | Hypochromic microcytic anemia (HP:0004840) | 1.97602663 |
| 155 | Abnormality of proline metabolism (HP:0010907) | 1.97516451 |
| 156 | Hydroxyprolinuria (HP:0003080) | 1.97516451 |
| 157 | Cholecystitis (HP:0001082) | 1.96894094 |
| 158 | Abnormal gallbladder physiology (HP:0012438) | 1.96894094 |
| 159 | Abnormality of the pericardium (HP:0001697) | 1.94509959 |
| 160 | Hemorrhage of the eye (HP:0011885) | 1.94240198 |
| 161 | Parakeratosis (HP:0001036) | 1.94107246 |
| 162 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90742145 |
| 163 | Nephritis (HP:0000123) | 1.90475728 |
| 164 | Spondylolisthesis (HP:0003302) | 1.89721600 |
| 165 | Cerebral inclusion bodies (HP:0100314) | 1.89293043 |
| 166 | Hyperuricemia (HP:0002149) | 1.89142002 |
| 167 | Increased purine levels (HP:0004368) | 1.89142002 |
| 168 | Hypergammaglobulinemia (HP:0010702) | 1.88739100 |
| 169 | Pulmonary embolism (HP:0002204) | 1.86862774 |
| 170 | Global brain atrophy (HP:0002283) | 1.86275642 |
| 171 | Glomerulopathy (HP:0100820) | 1.85085049 |
| 172 | Alkalosis (HP:0001948) | 1.84919035 |
| 173 | Hypoglycemic seizures (HP:0002173) | 1.84298526 |
| 174 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84213728 |
| 175 | Gastrointestinal infarctions (HP:0005244) | 1.84104455 |
| 176 | Abnormality of the pleura (HP:0002103) | 1.83821947 |
| 177 | Polycythemia (HP:0001901) | 1.83245430 |
| 178 | Joint swelling (HP:0001386) | 1.82525562 |
| 179 | Opisthotonus (HP:0002179) | 1.81365897 |
| 180 | Abnormality of the endocardium (HP:0004306) | 1.81127991 |
| 181 | Elevated hepatic transaminases (HP:0002910) | 1.80365266 |
| 182 | Spontaneous hematomas (HP:0007420) | 1.78970182 |
| 183 | Bone pain (HP:0002653) | 1.78547853 |
| 184 | Episodic fever (HP:0001954) | 1.78026154 |
| 185 | Thoracic kyphosis (HP:0002942) | 1.76455304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.95673208 |
| 2 | GRK7 | 3.42588639 |
| 3 | ERN1 | 3.26939157 |
| 4 | FGFR4 | 3.17363356 |
| 5 | TAOK3 | 3.12653782 |
| 6 | TYK2 | 3.06333496 |
| 7 | MAP3K14 | 2.98486341 |
| 8 | FLT3 | 2.63005028 |
| 9 | BLK | 2.56415921 |
| 10 | TBK1 | 2.50890926 |
| 11 | DDR2 | 2.46686591 |
| 12 | MATK | 2.35637109 |
| 13 | TAOK2 | 2.30106485 |
| 14 | MAP4K1 | 2.16913183 |
| 15 | MAP2K3 | 2.15090177 |
| 16 | PKN2 | 2.09971732 |
| 17 | FGR | 2.08989025 |
| 18 | SIK1 | 2.02813328 |
| 19 | BMPR2 | 1.95094647 |
| 20 | MOS | 1.90909421 |
| 21 | IRAK3 | 1.89232706 |
| 22 | PRPF4B | 1.84372182 |
| 23 | CSF1R | 1.84307930 |
| 24 | TXK | 1.84303739 |
| 25 | NME2 | 1.82143858 |
| 26 | KIT | 1.81798162 |
| 27 | JAK1 | 1.72016321 |
| 28 | IRAK4 | 1.69604368 |
| 29 | ABL2 | 1.68829890 |
| 30 | NEK9 | 1.64761347 |
| 31 | ADRBK2 | 1.63973626 |
| 32 | IKBKE | 1.56908486 |
| 33 | JAK3 | 1.49889888 |
| 34 | JAK2 | 1.45286610 |
| 35 | ERBB4 | 1.42715290 |
| 36 | EPHB1 | 1.41009935 |
| 37 | IKBKB | 1.39575040 |
| 38 | RIPK1 | 1.35805824 |
| 39 | TRIB3 | 1.35160921 |
| 40 | KDR | 1.32785132 |
| 41 | GRK6 | 1.31757554 |
| 42 | MAPK11 | 1.31197952 |
| 43 | CDC42BPA | 1.30337656 |
| 44 | TAOK1 | 1.30069368 |
| 45 | TGFBR2 | 1.25293140 |
| 46 | MAP3K13 | 1.22839740 |
| 47 | MAP2K4 | 1.20451160 |
| 48 | INSRR | 1.19900653 |
| 49 | MAP3K11 | 1.19711816 |
| 50 | PIK3CG | 1.17831143 |
| 51 | MAP3K3 | 1.17644159 |
| 52 | PTK6 | 1.15023398 |
| 53 | MAP3K10 | 1.13903927 |
| 54 | PRKAA2 | 1.05226095 |
| 55 | BTK | 1.02556076 |
| 56 | RIPK4 | 0.98222916 |
| 57 | PIM2 | 0.97515133 |
| 58 | MST1R | 0.94054449 |
| 59 | EPHA3 | 0.92108455 |
| 60 | CSK | 0.91322009 |
| 61 | SYK | 0.88786752 |
| 62 | ACVR1B | 0.88260073 |
| 63 | MAP3K5 | 0.86556591 |
| 64 | ZAP70 | 0.85901410 |
| 65 | CAMKK2 | 0.84761200 |
| 66 | MAP3K7 | 0.84216346 |
| 67 | MARK3 | 0.83656658 |
| 68 | TEC | 0.81558074 |
| 69 | MAPK4 | 0.81018718 |
| 70 | PBK | 0.78554199 |
| 71 | LRRK2 | 0.78371660 |
| 72 | PRKCQ | 0.77532074 |
| 73 | CHUK | 0.76469088 |
| 74 | PIM1 | 0.76158951 |
| 75 | CDK4 | 0.74583397 |
| 76 | LYN | 0.73387975 |
| 77 | FGFR3 | 0.68804198 |
| 78 | CDK6 | 0.68649015 |
| 79 | PINK1 | 0.68093807 |
| 80 | HCK | 0.67630821 |
| 81 | FES | 0.66822987 |
| 82 | DYRK1B | 0.63099022 |
| 83 | MAP3K6 | 0.62726367 |
| 84 | EIF2AK1 | 0.58363822 |
| 85 | MAPK12 | 0.58360127 |
| 86 | DYRK3 | 0.58125510 |
| 87 | STK10 | 0.58010546 |
| 88 | STK4 | 0.57293695 |
| 89 | PDPK1 | 0.56724759 |
| 90 | LCK | 0.56687214 |
| 91 | IRAK2 | 0.56543884 |
| 92 | NLK | 0.56164407 |
| 93 | STK3 | 0.54929092 |
| 94 | EGFR | 0.54306191 |
| 95 | SCYL2 | 0.53797080 |
| 96 | TRPM7 | 0.53488154 |
| 97 | MAP3K8 | 0.51475294 |
| 98 | ITK | 0.49403496 |
| 99 | ABL1 | 0.48877831 |
| 100 | CLK1 | 0.47433762 |
| 101 | TTN | 0.46300179 |
| 102 | SIK3 | 0.43724260 |
| 103 | PRKAA1 | 0.43522561 |
| 104 | MAPK7 | 0.43261896 |
| 105 | PDK1 | 0.43110129 |
| 106 | ARAF | 0.40962051 |
| 107 | PDGFRB | 0.40910476 |
| 108 | PDK2 | 0.40879875 |
| 109 | RET | 0.40385442 |
| 110 | PKN1 | 0.38384136 |
| 111 | GSK3A | 0.38348258 |
| 112 | MAP2K6 | 0.37514227 |
| 113 | RPS6KA4 | 0.37141433 |
| 114 | TIE1 | 0.36637477 |
| 115 | RPS6KL1 | 0.36122152 |
| 116 | RPS6KC1 | 0.36122152 |
| 117 | LATS2 | 0.35691052 |
| 118 | PRKACG | 0.35659563 |
| 119 | PRKCD | 0.35492207 |
| 120 | MAP2K2 | 0.35287214 |
| 121 | PAK4 | 0.35162654 |
| 122 | RAF1 | 0.33359028 |
| 123 | STK24 | 0.33096218 |
| 124 | TESK2 | 0.32435098 |
| 125 | BMX | 0.32228709 |
| 126 | IRAK1 | 0.31987349 |
| 127 | CAMK1D | 0.31924777 |
| 128 | INSR | 0.31640529 |
| 129 | MST4 | 0.31351358 |
| 130 | PDGFRA | 0.30769176 |
| 131 | RPS6KA6 | 0.30718822 |
| 132 | OBSCN | 0.30636491 |
| 133 | HIPK2 | 0.30621530 |
| 134 | MAP3K1 | 0.30457499 |
| 135 | LIMK1 | 0.28625582 |
| 136 | DAPK2 | 0.27740325 |
| 137 | KSR1 | 0.26568829 |
| 138 | RPS6KA2 | 0.25437159 |
| 139 | MAPKAPK2 | 0.25272725 |
| 140 | DAPK3 | 0.22650871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32594687 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.53245741 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38983624 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35427076 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84924270 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.73353861 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68422961 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66740962 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60476726 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54160712 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.48910459 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48834316 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45595041 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42461691 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.36964431 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19629337 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.17823069 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.17580351 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08005450 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05493114 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99413375 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97015118 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.90065627 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83308939 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83291634 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81191477 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80792866 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.77823147 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74469986 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71484657 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69743536 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.66523012 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66269609 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65686463 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63117374 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61297281 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60936228 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.58356849 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55933849 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52435853 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50893829 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50884621 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49635839 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47569654 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47081093 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46345045 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.45914609 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41004001 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39215242 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.35439351 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33504320 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33359021 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30835222 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30119577 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27644852 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24528527 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23573298 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21103665 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21043754 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19948146 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17154744 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14921245 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12215187 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11472753 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08355381 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07224184 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06824509 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 1.03825858 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02175142 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 1.00626693 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.99801868 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98337584 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97996686 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95516521 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.95050314 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93798850 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93277501 |
| 78 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90685231 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87875793 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87080085 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86414956 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86328597 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.86133737 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81919009 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.80126987 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.76520879 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76432294 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75183765 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74978186 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74715596 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74305918 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73990813 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72084924 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71586527 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.70328551 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68684845 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68601665 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67577797 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65369679 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64452430 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61980865 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54602702 |
| 103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52182213 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48561968 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.43942202 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43138821 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42805688 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40810337 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39263163 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.38424871 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36144564 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35008483 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33436542 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33333030 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33282719 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31267908 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29590881 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28620678 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.27823371 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.27058163 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26729139 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.26360620 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24477906 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23850986 |
| 125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23134570 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23025977 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22841197 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22764370 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22558762 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22146390 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21915733 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21316254 |
| 133 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20543221 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.20452903 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18511054 |
| 136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17135048 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.16474364 |
| 138 | Legionellosis_Homo sapiens_hsa05134 | 0.16396727 |
| 139 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15854694 |
| 140 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.15523676 |
| 141 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.15402896 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14081263 |
| 143 | Allograft rejection_Homo sapiens_hsa05330 | 0.13916937 |
| 144 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11919637 |
| 145 | Other glycan degradation_Homo sapiens_hsa00511 | 0.10716183 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.08205170 |
| 147 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07163008 |
| 148 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05290784 |
| 149 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.05061818 |
| 150 | Hepatitis C_Homo sapiens_hsa05160 | 0.04814530 |
| 151 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.04351848 |
| 152 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.03504770 |
| 153 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02269083 |
| 154 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.00624394 |
| 155 | Measles_Homo sapiens_hsa05162 | 0.00595051 |
| 156 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.00119367 |
| 157 | Tuberculosis_Homo sapiens_hsa05152 | -0.0421048 |
| 158 | Influenza A_Homo sapiens_hsa05164 | -0.0309440 |
| 159 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0162467 |
| 160 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0148149 |
| 161 | Malaria_Homo sapiens_hsa05144 | -0.0032664 |

